Sinus CancerSymptoms, Doctors, Treatments, Advances & More
Learn About Sinus Cancer
University Ear Nose And Throat Specialists
Carl H. Snyderman, MD, is a professor in the department of otolaryngology at the University of Pittsburgh School of Medicine and codirector of the UPMC Center for Skull Base Surgery. He specializes in otolaryngology-head and neck surgery, and cranial base surgery. Dr. Snyderman is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Cerebrospinal Fluid Leak, Olfactory Neuroblastoma, Sinus Cancer, Endoscopy, and Nerve Decompression. Dr. Snyderman is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Snyderman is currently accepting new patients.
Penn Pituitary Center
Nithin Adappa is an Otolaryngologist practicing medicine in Philadelphia, Pennsylvania. Dr. Adappa is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Cerebrospinal Fluid Leak, Sinusitis, Sinus Cancer, Endoscopy, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Adappa is board certified in Otolaryngology, 2011. Dr. Adappa is currently accepting new patients.
Mass Eye And Ear, Otolaryngology?Head And Neck Surgery
Derrick Lin is an Otolaryngologist practicing medicine in Boston, Massachusetts. Dr. Lin is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, Sinus Cancer, Laryngectomy, and Glossectomy. Dr. Lin is board certified in Otolaryngology-Head And Neck Surgery.
Summary: This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy (chemo-radiation) in patients with head and neck cancer. Ipatasertib is in a class of medications called protein kinase B (AKT) inhibitors. It may stop the growth of tumor cells and may kill them. Cisplatin, which is a chemotherapy ...
Summary: The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rur...